Automated breast ultrasound one step closer to FDA approval

Editorial Staff | | Health Imaging | Diagnostic Imaging
U-Systems has received a pre-market approvable (PMA) letter from the FDA for its somo•v Automated Breast Ultrasound (ABUS) system for breast cancer screening as an adjunct to mammography for asymptomatic women with dense breast tissue. 

Using technology to automate the ultrasound imaging process, the U-Systems’ somo•v ABUS system was developed for the high-volume, breast cancer screening environment. The somo•VIEWer Advanced 3D Workstation enables review and archive of patient exams.

Final approval of the company’s PMA application for the system remains subject to satisfactory review and inspection of U-Systems manufacturing facilities, methods and controls. The company said it plans to work with the FDA to complete this final inspection.

 

Editorial Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.